hypersensitivity vasculitis: Disorder characterized by a vasculitic syndrome associated with exposure to an antigen such as a drug, infectious agent, or other foreign or endogenous substance. Its pathophysiology includes immune complex deposition and a wide range of skin lesions. Hypersensitivity or allergy is present in some but not all cases.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
992 |
4. Check minimum number of eventsNone |
992 |
5. Include endpointsNone |
992 |
6. Filter based on genotype QC (FinnGen only) |
899 |
Control definitions (FinnGen only)
- Control exclude
- L12_OTHERSKINSUBCUTIS
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Other and unspecified vasculitis limited to skin
based on the number of shared cases.
Similar with more cases:
- Vasculitis limited to skin, not elsewhere classified
- Other disorders of skin and subcutaneous tissue
- Diseases of the skin and subcutaneous tissue
- Any prescribed medicine buy
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 5748 | 3379 | 2331 |
| Only index persons | 5105 | 3007 | 2098 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.08 | 0.10 | 0.07 |
| Only index persons | 0.10 | 0.11 | 0.08 |
| Median age at first event (years) | |||
| Whole population | 64.72 | 66.92 | 61.51 |
| Only index persons | 63.26 | 65.05 | 60.70 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 899 | 513 | 386 |
| Unadjusted period prevalence (%) | 0.18 | 0.18 | 0.18 |
| Median age at first event (years) | 62.66 | 61.43 | 64.30 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 932
- Matched controls
- 9320
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D69.0
ICD-10 Finland
Allergic purpura
157.1
316.6
157
12
L95.9
ICD-10 Finland
Vasculitis limited to skin, unspecified
8365.1
307.7
677
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
26.7
307.7
486
366
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
70.6
307.7
209
38
L95.8
ICD-10 Finland
Other vasculitis limited to skin
2385.7
307.7
406
*
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
54.5
200.4
115
24
S97
ICPC
Chronic ulcer skin
11.2
190.5
229
264
TQW80
NOMESCO Finland
Local dermatologic skincare
23.9
178.2
132
64
H02AB06
ATC
prednisolone; systemic
9.0
175.8
775
3305
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
13.4
171.2
175
158
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
29.4
137.4
93
35
L04AX01
ATC
azathioprine; systemic
11.5
133.5
149
152
I83.0
ICD-10 Finland
Varicose veins of lower extremities with ulcer
17.9
124.3
104
65
L30.9
ICD-10 Finland
Dermatitis, unspecified
4.6
105.7
367
1164
D07AC01
ATC
betamethasone; topical
4.3
104.2
545
2319
A46
ICD-10 Finland
Erysipelas
4.8
97.9
287
793
SPAT1148
SPAT
Treatment of chronic ulcer or burn
4.8
92.6
260
691
D07AD01
ATC
clobetasol; topical
4.4
87.0
281
829
J04BA02
ATC
dapsone; oral
114.6
86.7
93
9
QDG20
NOMESCO Finland
Operation for chronic ulcer or fistula of skin of lower limb
51.7
84.7
49
10
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
3.5
78.1
503
2333
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
11.0
77.8
86
85
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
5.9
75.0
151
298
E0000UV, ,
ATC
3.4
73.1
542
2706
J01FF01
ATC
clindamycin; systemic
3.4
69.7
385
1600
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
4.1
63.3
206
599
L04AA06
ATC
mycophenolic acid; systemic
12.7
63.2
63
53
L04AX03
ATC
methotrexate; systemic
4.4
62.6
181
482
L95.0
ICD-10 Finland
Livedoid vasculitis
+∞
62.2
59
*
XQ848
NOMESCO Finland
Dermatological photography
8.5
59.6
80
102
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.1
58.2
608
3532
P01BA02
ATC
hydroxychloroquine; oral
4.6
55.7
150
376
ZZA00
NOMESCO Finland
Split skin graft
8.4
55.6
75
96
C03CA01
ATC
furosemide; systemic
2.9
55.0
428
2103
D07AB08
ATC
desonide; topical
4.0
53.5
179
527
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.7
52.2
194
614
L50.9
ICD-10 Finland
Urticaria, unspecified
6.5
51.8
89
149
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
4.3
51.2
151
405
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
4.7
47.2
120
286
NHQ40
NOMESCO Finland
Amputation of toe
16.7
47.2
40
25
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.3
47.1
212
755
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
5.4
45.8
97
198
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
4.0
44.7
141
396
D09AB01
ATC
zinc bandage without supplements; topical
10.3
44.0
50
51
I83.1
ICD-10 Finland
Varicose veins of lower extremities with inflammation
8.5
43.1
57
71
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
4.3
42.9
122
317
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
3.4
41.2
169
565
S18
ICPC
Laceration/cut
2.5
41.1
541
3304
L04AA01
ATC
[U] ciclosporin
11.9
38.9
40
35
M04AA01
ATC
allopurinol; systemic
3.1
37.6
189
711
N02AX02
ATC
tramadol; systemic, rectal
2.4
37.3
494
2980
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.5
37.2
360
1888
L50.8
ICD-10 Finland
Other urticaria
8.4
37.0
49
61
A02BC02
ATC
pantoprazole; systemic
2.7
36.6
724
5216
E000001, ,
ATC
2.7
36.1
245
1082
H02AB09
ATC
hydrocortisone; systemic
6.9
35.6
56
85
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
10.4
35.6
40
40
QDB10, ,
SPAT
6.0
35.1
64
113
M31.9
ICD-10 Finland
Necrotizing vasculopathy, unspecified
187.0
35.0
36
*
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.1
34.7
165
600
L01BA01
ATC
methotrexate; systemic
5.6
34.2
67
127
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
3.1
33.7
166
615
N08.2*D89.80
ICD-10 Finland
Immunoglobulin A (IgA) nephropathy
38.9
32.7
41
11
N08.2*D69.0
ICD-10 Finland
Glomerular disorders in Henoch(-Schönlein) purpura
+∞
32.5
31
*
R60.0
ICD-10 Finland
Localized oedema
2.9
32.2
183
733
TQW11
NOMESCO Finland
Vacuum treatment of wound
7.4
32.0
47
66
J01DB01
ATC
cefalexin; oral
3.3
32.0
828
6564
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
4.5
31.7
82
197
H02AB07
ATC
prednisone; oral
2.8
31.4
182
736
SPAT1149
SPAT
Suture or treatment of traumatic wound
2.9
31.0
168
655
S76
ICPC
Skin infection other
4.1
30.7
91
242
L04AD01
ATC
ciclosporin; systemic
8.2
30.4
41
52
M13.9
ICD-10 Finland
Arthritis, unspecified
3.5
30.3
112
347
I50.9
ICD-10 Finland
Heart failure, unspecified
2.7
30.2
203
884
S29
ICPC
Skin symptom/complaint other
2.5
30.0
249
1200
L03.9
ICD-10 Finland
Cellulitis, unspecified
7.7
29.5
42
57
SPAT1151
SPAT
Treatment of major wounds
11.4
29.5
31
28
R50.9
ICD-10 Finland
Fever, unspecified
2.7
29.2
195
845
J01MA02
ATC
ciprofloxacin; systemic
2.2
28.9
422
2569
D07AC13
ATC
mometasone; topical
2.3
28.6
322
1766
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
10.3
28.4
32
32
N18.8
ICD-10 Finland
Other chronic renal failure
6.7
28.4
46
72
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.3
28.3
310
1678
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.1
27.9
130
464
PD4CG
NOMESCO Finland
Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet
9.2
27.8
34
38
M30.0
ICD-10 Finland
Polyarteritis nodosa
103.3
27.8
30
*
A41.9
ICD-10 Finland
Sepsis, unspecified
4.8
27.7
65
144
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.6
27.5
195
869
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
2.7
27.3
166
685
N02AA05
ATC
oxycodone; systemic
2.4
27.0
240
1186
B01AA03
ATC
warfarin; systemic
2.4
26.8
234
1147
D69.2
ICD-10 Finland
Other nonthrombocytopenic purpura
41.4
26.0
32
8
ZXE00
NOMESCO Finland
One hour or less
2.1
25.9
407
2520
C03DA01
ATC
spironolactone; oral
2.6
25.7
171
737
L98.9
ICD-10 Finland
Disorder of skin and subcutaneous tissue, unspecified
25.9
25.4
35
14
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.3
25.1
238
1204
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
3.3
25.0
103
341
I50.0
ICD-10 Finland
Congestive heart failure
3.0
24.9
118
424
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
3.6
24.8
85
250
D02AX
ATC
Other emollients and protectives
5.4
24.8
50
97
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
3.4
24.7
97
312
A10AB05
ATC
insulin aspart; parenteral
3.2
24.5
106
361
L89
ICD-10 Finland
Decubitus ulcer and pressure area
22.7
24.5
35
16
J01CF05
ATC
flucloxacillin; systemic
3.3
24.3
100
331
WZC30
NOMESCO Finland
Teaching
2.4
24.2
202
965
SPAT1211
SPAT
Application of soft bandage
3.0
23.8
114
412
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
6.4
23.8
40
65
R4180
NOMESCO Finland
Podiatric therapy
9.6
23.6
28
30
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
3.3
23.0
92
299
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
4.8
22.9
53
116
J01MA12
ATC
levofloxacin; systemic
2.3
22.9
215
1080
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
3.3
22.8
89
285
Z3231
NOMESCO Finland
Registered nurse
2.1
22.4
295
1690
KA1AE
NOMESCO Finland
Kidney ultrasound examination
5.2
22.1
46
92
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.4
21.9
85
271
L08.9
ICD-10 Finland
Local infection of skin and subcutaneous tissue, unspecified
4.5
21.8
55
129
A02BC01
ATC
omeprazole; systemic
2.1
21.5
292
1689
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.3
21.4
202
1013
XF600
NOMESCO Finland
Bloodpressure measurement
3.2
21.2
88
292
L52
ICD-10 Finland
Erythema nodosum
17.1
21.1
33
20
E000003, ,
ATC
3.8
21.0
66
183
A10AC01
ATC
insulin (human); parenteral
3.0
20.9
101
366
I83.2
ICD-10 Finland
Varicose veins of lower extremities with both ulcer and inflammation
20.0
20.9
31
16
L81.7
ICD-10 Finland
Pigmented purpuric dermatosis
78.6
20.8
23
*
D69
ICD-10 Finland
Purpura and other haemorrhagic conditions
78.6
20.8
23
*
D64.9
ICD-10 Finland
Anaemia, unspecified
2.6
20.7
140
604
UJF32
NOMESCO Finland
Coloscopy
2.0
20.7
283
1636
R06AE09
ATC
levocetirizine; oral
2.4
20.7
157
715
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.7
20.6
117
463
L03.1
ICD-10 Finland
Cellulitis of other parts of limb
4.4
20.4
52
123
ZXE10
NOMESCO Finland
More than one and less than three hours
1.9
20.4
365
2317
ZY010
NOMESCO Finland
Hospital outpatient
3.6
20.1
69
203
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
3.1
20.0
91
319
N03AX16
ATC
[U] pregabalin
2.1
19.7
246
1373
B01AB05
ATC
enoxaparin; parenteral
1.9
19.4
334
2086
ZXD05
NOMESCO Finland
Urgent procedure
2.0
19.2
306
1860
I48
ICD-10 Finland
Atrial fibrillation and flutter
2.0
19.2
249
1408
R06.0
ICD-10 Finland
Dyspnoea
2.0
19.1
304
1847
TPH04
NOMESCO Finland
Cathetrisation of vein
2.1
18.9
242
1360
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
4.0
18.9
55
144
L88
ICD-10 Finland
Pyoderma gangrenosum
+∞
18.8
18
*
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
2.3
18.8
156
738
WX213
NOMESCO Finland
Lower leg blockade
17.6
18.8
29
17
D07AB02
ATC
hydrocortisone butyrate; topical
1.9
18.8
305
1864
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
3.8
18.5
58
160
N03AX12
ATC
[U] gabapentin; oral
2.2
18.5
184
939
PF1AT
NOMESCO Finland
Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)
18.0
18.3
28
16
A07EC01
ATC
sulfasalazine; oral, rectal
2.8
18.3
98
376
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
3.2
18.3
74
242
PD4AC
NOMESCO Finland
Arterigography of lower extremity with X-ray
6.4
18.1
30
48
N17.9
ICD-10 Finland
Acute renal failure, unspecified
3.5
18.1
64
192
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.7
18.1
108
438
L88
ICPC
Rheumatoid/seropositive arthritis
3.7
17.7
58
165
M05BA04
ATC
alendronic acid; oral
2.5
17.4
116
496
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.5
17.4
61
182
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.1
17.3
194
1034
PD4DE
NOMESCO Finland
Lower extremity artery ultrasound examination with Doppler method
5.1
17.0
36
73
XW000
NOMESCO Finland
Bone marrow biopsy
3.6
16.8
58
171
R23.3
ICD-10 Finland
Spontaneous ecchymoses
4.8
16.7
38
82
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.6
16.7
108
455
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
3.1
16.7
71
239
M31.8
ICD-10 Finland
Other specified necrotizing vasculopathies
91.7
16.6
18
*
SPAT1260
SPAT
Consultation of another employee
2.1
16.5
186
993
E11.5
ICD-10 Finland
Type 2 diabetes mellitus, with peripheral circulatory complications
5.5
16.5
32
60
JN4AD
NOMESCO Finland
Body CT examination
2.3
16.3
135
636
D07BC01
ATC
betamethasone and antiseptics; topical
2.3
15.9
127
589
L17
ICPC
Foot/toe symptom/complaint
1.8
15.9
312
2006
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
3.9
15.8
47
125
NH3EA
NOMESCO Finland
Feet X-ray examination with load
5.6
15.8
30
55
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
3.6
15.7
53
154
JN3AD
NOMESCO Finland
Abdominal CT examination
2.2
15.7
143
701
L28
ICPC
Limited function/disability (L)
2.0
15.7
213
1214
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.4
15.6
117
528
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.9
15.6
253
1531
PD4BC
NOMESCO Finland
Extensive arterigography of lower extremity with X-ray
6.6
15.4
25
39
E000006, ,
ATC
2.8
15.4
81
307
B01AB04
ATC
dalteparin; parenteral
3.1
15.4
66
223
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
4.2
15.3
41
101
205
Kela drug reimbursment
Chronic hypertension
1.9
15.3
277
1734
R06AE07
ATC
cetirizine; oral
1.7
15.1
409
2880
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
5.1
15.1
32
65
R60.9
ICD-10 Finland
Oedema, unspecified
2.9
15.0
73
265
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.2
15.0
149
756
D69.9
ICD-10 Finland
Haemorrhagic condition, unspecified
15.4
14.9
24
16
TK800
NOMESCO Finland
Hemodialysis
5.1
14.9
31
62
R06AX27
ATC
desloratadine; oral
1.8
14.8
268
1673
C07AB07
ATC
bisoprolol; oral
1.7
14.8
493
3673
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.6
14.6
92
382
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.7
14.6
418
2982
R03DC03
ATC
montelukast; oral
2.0
14.5
172
931
SPAT1262
SPAT
Handing over of treatment supplies
2.0
14.5
181
999
NHQ30
NOMESCO Finland
Amputation of foot, transmetatarsal
36.7
14.5
18
5
L30.3
ICD-10 Finland
Infective dermatitis
3.6
14.5
48
138
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
4.2
14.3
38
93
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
4.2
14.3
38
93
ZX120
NOMESCO Finland
Intravenous
2.4
14.3
105
469
J01MA14
ATC
moxifloxacin; systemic
2.4
14.2
102
451
A12AA04
ATC
calcium carbonate; oral
6.5
14.1
23
36
D03BA02
ATC
collagenase; topical
43.2
14.1
17
*
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
4.5
14.1
34
77
ZX112
NOMESCO Finland
Subcutaneous
4.2
14.0
37
90
Z2446
NOMESCO Finland
Social worker
2.7
13.9
76
294
G47.3
ICD-10 Finland
Sleep apnoea
1.9
13.8
228
1381
M10.9
ICD-10 Finland
Gout, unspecified
2.6
13.6
84
345
A08
ICPC
Swelling
2.7
13.6
78
309
M79.6
ICD-10 Finland
Pain in limb
1.7
13.3
421
3061
B01AB10
ATC
tinzaparin; parenteral
2.2
13.3
123
605
NG4AA
NOMESCO Finland
Lower leg X-ray examination
3.5
13.3
46
136
QXB99, ,
SPAT
3.9
13.3
39
103
L50.3
ICD-10 Finland
Dermatographic urticaria
5.0
13.2
28
57
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.3
13.1
105
487
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
2.1
13.0
126
632
L01AA01
ATC
cyclophosphamide; systemic
19.4
12.9
19
10
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
4.9
12.9
28
58
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
2.8
12.9
66
247
I50.1
ICD-10 Finland
Left ventricular failure
2.8
12.8
64
236
S21
ICPC
Skin texture symptom/complaint
2.0
12.8
159
874
Z2221
NOMESCO Finland
Medical doctor
1.8
12.7
260
1673
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.8
12.7
250
1592
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
4.7
12.7
29
63
M79.3
ICD-10 Finland
Panniculitis, unspecified
32.5
12.6
16
5
N03.9
ICD-10 Finland
Chronic nephritic syndrome, unspecified
32.5
12.6
16
5
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.9
12.6
169
954
WX408
NOMESCO Finland
General anesthesy, balanced
1.8
12.5
245
1555
L14
ICPC
Leg/thigh symptom/complaint
2.3
12.5
97
443
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.6
12.4
73
293
Z01.8
ICD-10 Finland
Other specified special examinations
1.8
12.4
223
1381
E000002, ,
ATC
2.2
12.3
106
506
X59
ICD-10 Finland
Exposure to unspecified factor
1.9
12.2
186
1092
L50
ICD-10 Finland
Urticaria
4.8
12.2
27
57
N02AJ06
ATC
codeine and paracetamol; systemic
1.6
12.1
400
2920
A10AE04
ATC
insulin glargine; parenteral
2.2
12.1
107
517
TPH07
NOMESCO Finland
Cathetrisation of artery
2.1
12.0
124
636
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
2.6
12.0
73
298
D07BA04
ATC
hydrocortisone and antiseptics; topical
2.3
12.0
98
458
N08.2
ICD-10 Finland
Glomerular disorders in blood diseases and disorders involving the immune mechanism
47.3
11.9
14
*
344
Kela drug reimbursment
Omalizumab
47.3
11.9
14
*
A07AA09
ATC
vancomycin; oral
5.5
11.9
23
43
H02AB04
ATC
methylprednisolone; systemic
2.0
11.8
141
764
I10
ICD-10 Finland
Essential (primary) hypertension
1.6
11.7
591
4779
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.4
11.7
86
384
I50
ICD-10 Finland
Heart failure
3.2
11.7
46
148
L08.8
ICD-10 Finland
Other specified local infections of skin and subcutaneous tissue
3.5
11.6
40
118
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
3.5
11.6
40
118
C08DB01
ATC
diltiazem; oral
2.7
11.6
64
249
C08CA05
ATC
nifedipine; systemic
2.6
11.6
68
273
M05.2
ICD-10 Finland
Rheumatoid vasculitis
+∞
11.5
11
*
ZXD10
NOMESCO Finland
Scheduled procedure
1.6
11.5
347
2470
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.6
11.5
476
3662
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.6
11.4
380
2768
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.1
11.3
109
544
S81.9
ICD-10 Finland
Open wound of lower leg, part unspecified
9.8
11.3
22
23
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.8
11.3
189
1142
R4190
NOMESCO Finland
Nutritional therapy
3.1
11.3
48
162
R03BB04
ATC
tiotropium bromide; inhalant
2.1
11.2
110
553
L84
ICD-10 Finland
Corns and callosities
3.6
11.1
36
102
Z3226
NOMESCO Finland
Physiotherapist
1.8
11.1
176
1046
TGC00
NOMESCO Finland
Bronchial lavation
3.5
11.1
38
112
J45.9
ICD-10 Finland
Asthma, unspecified
1.8
11.0
190
1157
N19
ICD-10 Finland
Unspecified kidney failure
2.9
11.0
52
186
XF400
NOMESCO Finland
ECG with 12 standard connections
1.9
11.0
158
910
SPAT1263
SPAT
Sampling
1.6
10.9
382
2808
A28
ICPC
Limited function/disability NOS
1.8
10.9
198
1224
J01DA01
ATC
[U] cefalexin
1.6
10.9
556
4472
B35.3
ICD-10 Finland
Tinea pedis
2.8
10.8
53
194
B01AF02
ATC
apixaban; oral
1.9
10.7
148
841
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.8
10.6
188
1155
L27.0
ICD-10 Finland
Generalized skin eruption due to drugs and medicaments
5.1
10.6
22
44
XQ800
NOMESCO Finland
Prick test
2.5
10.5
69
292
UJF30
NOMESCO Finland
Ileoscopy through colon
2.1
10.5
106
538
D02AE01
ATC
carbamide; topical
2.5
10.5
68
286
Z71.8
ICD-10 Finland
Other specified counselling
1.6
10.5
312
2200
SPAT1153
SPAT
Removal of sutures
1.6
10.5
290
2008
S99
ICPC
Skin disease other
3.8
10.5
32
87
207
Kela drug reimbursment
Chronic arrhythmias
1.8
10.4
167
993
M31.0
ICD-10 Finland
Hypersensitivity angiitis
+∞
10.4
10
*
M36.4*D69.0
ICD-10 Finland
Arthropathy in Henoch(-Schönlein) purpura
+∞
10.4
10
*
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.2
10.4
86
404
NFQ20
NOMESCO Finland
Amputation of femur
12.2
10.4
18
15
R03DX05
ATC
omalizumab; parenteral
32.9
10.3
13
*
L04AA13
ATC
[U] leflunomide
3.7
10.3
32
88
N02BE01
ATC
paracetamol; systemic, rectal
2.0
10.3
832
7493
QDA10
NOMESCO Finland
Incision of skin of lower limb
13.3
10.2
17
13
C08CA13
ATC
lercanidipine; oral
1.9
10.2
152
885
A06AD11
ATC
lactulose; oral
1.9
10.1
148
855
PF1BT
NOMESCO Finland
Extensive PTA of arteries of knee, lower leg and ankle
14.8
10.0
16
11
A11CC03
ATC
alfacalcidol; systemic
3.9
10.0
29
76
SPAT1225
SPAT
Implementation of podiatry rehabilitation plan
3.8
9.9
30
81
QD9S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in lower extremities, unspecified
16.9
9.9
15
9
WX723
NOMESCO Finland
CPAP therapy
2.8
9.9
50
186
ZX108
NOMESCO Finland
Inhalation
12.3
9.9
17
14
R4110
NOMESCO Finland
Physiotherapy
1.6
9.9
261
1783
S91.3
ICD-10 Finland
Open wound of other parts of foot
3.6
9.8
32
91
QDA99
NOMESCO Finland
Other local destruction of skin of lower limb
26.3
9.8
13
5
QDE35
NOMESCO Finland
Repair of skin defect in lower limb after surgery or injury
20.3
9.8
14
7
A10AE05
ATC
insulin detemir; parenteral
2.5
9.8
60
246
B99
ICD-10 Finland
Other and unspecified infectious diseases
3.9
9.7
28
73
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.0
9.7
107
561
C01AA05
ATC
digoxin; systemic
2.2
9.7
88
429
V03AE01
ATC
polystyrene sulfonate; oral
5.4
9.7
19
36
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
3.4
9.7
34
102
A12BA01
ATC
potassium chloride; oral
2.6
9.6
55
218
L30.0
ICD-10 Finland
Nummular dermatitis
2.9
9.6
44
155
L40.0
ICD-10 Finland
Psoriasis vulgaris
3.0
9.5
43
150
XQ902
NOMESCO Finland
Other photography
7.2
9.5
22
31
E66.8
ICD-10 Finland
Other obesity
2.6
9.5
57
231
SPAT1255
SPAT
Intravenous administration of medicine
2.4
9.5
68
300
T90
ICPC
Diabetes non-insulin dependent
1.7
9.4
232
1554
L59.9
ICD-10 Finland
Disorder of skin and subcutaneous tissue related to radiation, unspecified
+∞
9.4
9
*
L94.2
ICD-10 Finland
Calcinosis cutis
+∞
9.4
9
*
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
4.4
9.4
23
53
XCW99
NOMESCO Finland
Other investigative procedure of eye
2.0
9.3
107
569
A02BC05
ATC
esomeprazole; systemic
1.6
9.3
366
2740
N02BF02
ATC
pregabalin; oral
2.3
9.2
71
323
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
9.2
323
2353
R11
ICD-10 Finland
Nausea and vomiting
2.1
9.2
93
473
M05BA07
ATC
risedronic acid; oral
3.0
9.2
40
137
WZC00
NOMESCO Finland
Treatment plan or consultation
1.6
9.2
330
2420
C08CA02
ATC
felodipine; oral
2.0
9.1
98
509
ZXC50
NOMESCO Finland
Cryotherapy
3.3
9.1
34
106
S11
ICPC
Skin infection post-traumatic
4.8
9.1
20
42
I80.3
ICD-10 Finland
Phlebitis and thrombophlebitis of lower extremities, unspecified
2.7
9.1
47
177
S19
ICPC
Skin injury other
2.7
9.1
47
177
R03AC02
ATC
salbutamol; inhalant
1.5
9.1
497
3991
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.8
9.0
45
166
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
3.0
9.0
39
133
R07.4
ICD-10 Finland
Chest pain, unspecified
1.6
9.0
269
1888
D01AE15
ATC
terbinafine; topical
2.3
9.0
72
334
GD1AD
NOMESCO Finland
Thorax CT examination
2.3
8.9
70
321
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.7
8.9
170
1062
R5110, ,
SPAT
2.0
8.9
96
500
103
Kela drug reimbursment
Diabetes, insulin-treated
1.6
8.9
253
1754
C02AC05
ATC
moxonidine; oral
2.5
8.8
56
234
C08CA01
ATC
amlodipine; oral
1.5
8.7
365
2760
NGQ20
NOMESCO Finland
Amputation of lower leg
14.2
8.7
14
10
M06.0
ICD-10 Finland
Seronegative rheumatoid arthritis
3.3
8.7
32
99
D47.2
ICD-10 Finland
Monoclonal gammopathy of undetermined significance (MGUS)
4.8
8.6
19
40
J01FA06
ATC
roxithromycin; oral
1.5
8.6
351
2638
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.7
8.6
45
171
I77.6
ICD-10 Finland
Arteritis, unspecified
16.5
8.6
13
8
J45.0
ICD-10 Finland
Predominantly allergic asthma
2.1
8.6
86
436
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.7
8.5
204
1353
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
2.1
8.5
86
437
WX892
NOMESCO Finland
Monitored bed care
2.1
8.5
78
382
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.6
8.4
242
1678
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.6
8.4
215
1449
ZXE20
NOMESCO Finland
More than three and less than five hours
1.8
8.4
128
748
L95.1
ICD-10 Finland
Erythema elevatum diutinum
+∞
8.3
8
*
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
8.6
8.3
17
20
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
2.0
8.3
97
519
K07
ICPC
Swollen ankles/oedema
2.4
8.3
58
253
C09BA02
ATC
enalapril and diuretics; systemic
2.1
8.3
80
399
WX002
NOMESCO Finland
Sedation and analgesia
1.7
8.3
177
1139
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
3.3
8.3
31
97
E11
ICD-10 Finland
Type 2 diabetes mellitus
1.7
8.2
155
963
WZA10
NOMESCO Finland
Extensive medical or dental certificate
4.3
8.2
21
50
C09AA02
ATC
enalapril; systemic
1.7
8.2
181
1175
WX006
NOMESCO Finland
Intravenous sedation or analgesia without general anesthesia
2.2
8.2
69
327
XX2RW, ,
NOMESCO Finland
4.6
8.1
19
42
ED1AA
NOMESCO Finland
Mandibular X-ray examination
8.2
8.1
17
21
M30.8
ICD-10 Finland
Other conditions related to polyarteritis nodosa
33.7
8.1
10
*
C07AB02
ATC
metoprolol; systemic
1.6
8.1
189
1245
J01AA02
ATC
doxycycline; systemic
1.6
8.1
694
6061
J45.1
ICD-10 Finland
Nonallergic asthma
2.2
8.1
72
349
M86.9
ICD-10 Finland
Osteomyelitis, unspecified
10.1
8.0
15
15
SPAT1249
SPAT
Treatment-related counselling outside office
1.5
8.0
337
2538
Z49.1
ICD-10 Finland
Extracorporeal dialysis
6.4
8.0
20
32
TNX92, ,
SPAT
22.2
8.0
11
5
SPAT1229
SPAT
Assessment of need for aid
2.1
8.0
76
377
PE1AT
NOMESCO Finland
Femoral artery PTA
6.2
7.9
20
33
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.8
7.9
127
755
D07AA02
ATC
hydrocortisone; topical
1.8
7.8
126
749
SPAT1310
SPAT
Counselling related to known health issue
1.5
7.8
275
1994
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.2
7.8
68
327
I73.0
ICD-10 Finland
Raynaud syndrome
3.9
7.7
22
57
Z53.2
ICD-10 Finland
Procedure not carried out because of patient's decision for other and unspecified reasons
3.9
7.7
22
57
M31.3
ICD-10 Finland
Wegener granulomatosis
15.2
7.7
12
8
QDB99
NOMESCO Finland
Other procedure for wound of skin of lower limb
15.2
7.7
12
8
P01AB01
ATC
metronidazole; oral, rectal
1.5
7.7
343
2610
E11.4
ICD-10 Finland
Type 2 diabetes mellitus, with neurological complications
3.5
7.7
26
76
M80.9
ICD-10 Finland
Unspecified osteoporosis with pathological fracture
3.3
7.7
28
86
N08.39*E11.2
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
4.0
7.6
21
53
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
2.2
7.6
66
316
ZYC01
NOMESCO Finland
Remote contact by phone
2.2
7.6
63
296
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
2.5
7.6
45
182
M30.1
ICD-10 Finland
Polyarteritis with lung involvement [Churg-Strauss]
25.2
7.6
10
*
E66.2
ICD-10 Finland
Extreme obesity with alveolar hypoventilation
6.2
7.6
19
31
EB1JA
NOMESCO Finland
Double panorama tomography of teeth and jaws or similar X-ray examination
8.9
7.6
15
17
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
3.9
7.6
22
58
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.6
7.5
236
1664
N30.0
ICD-10 Finland
Acute cystitis
1.7
7.5
159
1018
SPAT1301
SPAT
No procedures
1.5
7.5
275
2006
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.3
7.5
54
239
S01
ICPC
Pain/tenderness of skin
2.4
7.5
51
220
B03XA02
ATC
darbepoetin alfa; parenteral
3.6
7.5
24
68
S91.0
ICD-10 Finland
Open wound of ankle
6.5
7.4
18
28
UJF92
NOMESCO Finland
Capsular endoscopy
3.5
7.4
25
73
XQ841
NOMESCO Finland
Examination of dermatosis with microscope
80.7
7.4
8
*
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.8
7.4
117
692
4019X
ICD-9 Finland
Essential hypertension, Unspecified
3.0
7.3
32
110
A18.4
ICD-10 Finland
Tuberculosis of skin and subcutaneous tissue
+∞
7.3
7
*
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.1
7.3
71
356
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
3.4
7.3
25
74
WW200
NOMESCO Finland
Immunization
3.4
7.3
25
74
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
2.2
7.3
63
302
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
2.5
7.3
43
174
V03AE02
ATC
sevelamer; oral
15.9
7.2
11
7
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
2.9
7.2
34
122
J01FA10
ATC
azithromycin; systemic
1.5
7.2
483
3965
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.5
7.2
383
3010
UKC02
NOMESCO Finland
Cystoscopy
1.7
7.2
145
918
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.6
7.2
223
1569
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.5
7.2
264
1927
L50.1
ICD-10 Finland
Idiopathic urticaria
8.0
7.1
15
19
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
8.0
7.1
15
19
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
2.7
7.1
38
146
S06
ICPC
Rash localized
2.2
7.1
56
258
L50.0
ICD-10 Finland
Allergic urticaria
3.1
7.1
29
96
R5140
NOMESCO Finland
Monitoring the use of the aid
1.8
7.1
105
608
WX212
NOMESCO Finland
Femoral plexus blockade
3.0
7.1
31
107
212
Kela drug reimbursment
Gout
3.7
7.1
22
61
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
2.4
7.0
49
214
SPAT1254
SPAT
Administration of medicine
1.7
7.0
141
890
ZXA10
NOMESCO Finland
Bilateral
1.6
7.0
173
1151
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
3.2
7.0
27
86
S17
ICPC
Abrasion/scratch/blister
3.2
7.0
27
86
M10.0
ICD-10 Finland
Idiopathic gout
2.7
7.0
38
147
D05BB02
ATC
acitretin; oral
3.4
7.0
25
76
Z96.6
ICD-10 Finland
Presence of orthopaedic joint implants
2.3
7.0
54
247
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
2.4
7.0
46
196
WX402
NOMESCO Finland
General anaesthesia
1.6
7.0
189
1287
A07AA02
ATC
nystatin; oral
2.2
7.0
57
267
N18.0
ICD-10 Finland
End-stage renal disease
7.6
6.9
15
20
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.7
6.9
145
927
40199
ICD-8 Finland
Essential benign hypertension
3.5
6.9
23
67
L02.2
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of trunk
2.4
6.9
44
185
S20
ICPC
Corn/callosity
3.4
6.9
24
72
A10BA02
ATC
metformin; oral
1.5
6.9
260
1906
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
1.9
6.9
89
494
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
2.9
6.8
31
109
L02.8
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of other sites
4.2
6.8
18
44
K50.8
ICD-10 Finland
Other Crohn disease
4.2
6.8
18
44
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.6
6.8
151
978
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.4
6.8
45
192
J01CE08
ATC
benzathine benzylpenicillin; parenteral
5.7
6.8
18
32
L95
ICD-10 Finland
Vasculitis limited to skin, not elsewhere classified
40.4
6.8
8
*
QXB10
NOMESCO Finland
Exchange of dressing for large skin wound, unspecified location
16.8
6.8
10
6
QXA05
NOMESCO Finland
Skin division, unspecified location
16.8
6.8
10
6
QXA20
NOMESCO Finland
Skin abrasion, unspecified location
16.8
6.8
10
6
C01DA14
ATC
isosorbide mononitrate; oral
1.7
6.7
147
949
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2.1
6.7
59
285
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
1.8
6.7
99
573
L93.0
ICD-10 Finland
Discoid lupus erythematosus
22.7
6.7
9
*
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.6
6.7
147
951
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.8
6.7
98
566
ND2DA
NOMESCO Finland
Bilateral hand X-ray examination
3.8
6.7
20
54
A02BA02
ATC
ranitidine; systemic
1.6
6.6
175
1183
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.5
6.6
42
176
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
1.9
6.6
89
500
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
2.3
6.6
48
214
J01CF02
ATC
cloxacillin; systemic
3.5
6.6
22
64
N06AX21
ATC
duloxetine; oral
1.8
6.6
106
630
RJ411, ,
NOMESCO Finland
10.1
6.5
12
12
OAB50, ,
SPAT
1.9
6.5
78
421
XX9XE
NOMESCO Finland
Other ultrasound examination
6.9
6.5
15
22
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
2.5
6.5
41
171
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
3.1
6.5
26
85
R01AD08
ATC
fluticasone; nasal
1.5
6.5
233
1686
M81.9
ICD-10 Finland
Osteoporosis, unspecified
2.2
6.5
51
235
R58
ICD-10 Finland
Haemorrhage, not elsewhere classified
3.6
6.5
21
60
K70.3
ICD-10 Finland
Alcoholic cirrhosis of liver
4.0
6.5
18
46
JN4BD
NOMESCO Finland
Extensive body CT
1.8
6.5
97
564
XQ845
NOMESCO Finland
Dermatoscopy
3.4
6.4
22
65
M05.9
ICD-10 Finland
Seropositive rheumatoid arthritis, unspecified
3.0
6.4
27
91
T79.3
ICD-10 Finland
Post-traumatic wound infection, not elsewhere classified
3.8
6.4
19
51
R53
ICD-10 Finland
Malaise and fatigue
1.5
6.4
227
1639
K92.1
ICD-10 Finland
Melaena
2.1
6.4
57
277
ZXA00
NOMESCO Finland
Right side
1.5
6.4
229
1658
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
3.6
6.3
20
56
ZZR00
NOMESCO Finland
Flap of skin
3.2
6.3
24
76
R06.2
ICD-10 Finland
Wheezing
2.3
6.3
44
193
I35.0
ICD-10 Finland
Aortic (valve) stenosis
2.0
6.3
66
341
I48.1
ICD-10 Finland
Persistent atrial fibrillation
2.3
6.3
46
206
L94.8
ICD-10 Finland
Other specified localized connective tissue disorders
+∞
6.3
6
*
M30
ICD-10 Finland
Polyarteritis nodosa and related conditions
+∞
6.3
6
*
NH1AE
NOMESCO Finland
Ankle joint ultrasound examination
7.1
6.2
14
20
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
3.7
6.2
19
52
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
2.0
6.2
70
371
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
1.8
6.2
88
504
D07XC01
ATC
betamethasone; topical
1.8
6.1
101
603
C09AA05
ATC
ramipril; oral
1.5
6.1
231
1686
SPAT1312
SPAT
General health counselling
1.5
6.1
260
1943
QCB05
NOMESCO Finland
Revision of wound of skin of upper limb
7.7
6.1
13
17
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.6
6.1
142
930
Z02.7
ICD-10 Finland
Issue of medical certificate
1.9
6.1
75
409
Y96.9
ICD-10 Finland
Unspecified type of accident
3.1
6.1
25
83
TNG34
NOMESCO Finland
Major custom moulded orthopaedic cast, knee or lower leg
3.8
6.1
18
48
ZYC06
NOMESCO Finland
Real-time text-based remote transaction
12.6
6.1
10
8
R4120
NOMESCO Finland
Occupational therapy
2.0
6.1
62
317
XX3DW
NOMESCO Finland
Time consuming IT work
1.8
6.1
99
590
PH2DE
NOMESCO Finland
Ultrasound examination of bloodflow in veins of lower extremity with Doppler method
2.8
6.1
30
111
A10BH01
ATC
sitagliptin; oral
1.8
6.1
91
529
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
1.9
6.1
78
432
M25.5
ICD-10 Finland
Pain in joint
1.5
6.1
280
2127
XX1XW
NOMESCO Finland
Extensive written report from radiologist
3.2
6.0
23
73
L30.8
ICD-10 Finland
Other specified dermatitis
2.9
6.0
28
100
A01AB09
ATC
miconazole; local oral
1.9
6.0
79
440
PE1YT
NOMESCO Finland
Femoral or popliteal artery PTA with stent
5.6
6.0
16
29
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.5
6.0
241
1781
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
372
233
25.91
307.65
1.9
1.6
1.23
1.20
g/l
0.65
362
224
413
340
21.02
307.65
1.9
1.5
34.63
12.01
iu/ml
—
9
10
372
228
26.49
307.65
1.9
1.6
0.24
0.24
g/l
0.01
361
220
303
320
13.55
273.08
2.3
1.8
6.27
8.63
iu/ml
0.52
72
68
288
295
13.68
264.41
1.4
1.2
1.47
1.89
u/ml
0.09
18
15
186
147
15.56
198.08
1.4
1.2
96.25
395.00
titre
0.75
16
12
296
708
5.66
122.47
2.4
3.0
66.90
66.79
g/l
0.08
280
650
151
179
9.87
120.93
1.4
1.2
1.25
8.87
u/ml
—
8
11
166
224
8.80
119.91
1.4
1.2
4.51
10.50
u/ml
0.55
21
34
166
226
8.72
119.00
1.4
1.2
8.77
2.64
u/ml
0.49
13
20
167
233
8.51
117.22
1.4
1.2
71.94
25.37
u/ml
—
8
6
129
176
8.35
91.57
1.4
1.2
52.89
65.25
u/ml
0.20
14
16
245
650
4.76
87.00
4.4
2.7
11.00
10.98
g/l
0.02
231
596
102
111
10.20
86.38
1.3
1.2
5.52
5.11
u/ml
0.05
48
36
266
803
4.24
79.12
3.0
2.0
324.34
378.49
nmol/l
4.43
256
747
164
344
5.57
76.27
2.3
2.4
7.30
7.47
g/l
0.56
159
313
204
520
4.74
75.39
2.2
1.6
1.21
1.29
g/l
0.26
189
481
758
4669
4.34
73.13
16.5
9.7
4.81
4.12
e9/l
11.96
699
4056
146
295
5.68
70.53
2.7
2.6
0.57
1.18
g/l
1.11
132
256
152
322
5.45
69.65
2.4
2.4
3.12
3.04
g/l
0.37
147
291
135
257
5.97
69.47
2.6
2.5
0.03
0.02
g/l
0.11
128
233
488
2382
3.20
66.62
5.5
3.2
0.31
0.46
e6/l
1.34
411
1763
144
305
5.40
65.86
2.3
2.4
10.74
10.71
g/l
0.02
139
273
532
2781
3.13
63.48
5.8
3.3
71.85
82.43
e6/l
0.08
459
2147
627
3623
3.23
62.22
25.4
11.2
0.00
0.00
e9/l
0.16
559
2958
70
71
10.58
62.03
1.3
1.2
194.71
119.00
titre
—
17
10
419
1945
3.10
61.20
4.7
2.5
4.98
5.80
e6/l
0.58
399
1785
125
251
5.60
60.49
2.8
2.6
0.01
0.00
g/l
0.50
116
222
246
863
3.51
56.91
6.3
3.4
—
—
—
0
0
303
1211
3.23
56.65
3.6
2.4
20.92
22.15
%
0.77
285
1132
561
3149
2.96
56.61
7.1
3.9
76.47
133.40
e6/l
0.74
468
2243
224
773
3.50
52.82
2.7
2.5
77.23
69.12
e9/l
1.98
160
577
47
33
14.95
52.22
1.1
1.2
1.04
1.08
ratio
1.03
42
28
325
1411
3.00
51.91
3.5
2.4
11.18
12.67
umol/l
3.48
305
1316
309
1313
3.02
51.19
3.5
2.4
2.26
2.31
g/l
0.67
284
1216
77
114
7.27
50.30
1.4
1.2
3.03
5.92
u/ml
0.74
37
49
113
245
5.11
49.89
1.5
1.3
—
—
—
0
0
608
3713
2.83
49.72
8.6
5.0
33.92
35.53
g/l
9.50
591
3481
331
1483
2.91
49.53
1.4
1.3
34.17
31.97
iu/ml
0.16
111
462
247
950
3.18
48.38
4.5
4.2
246.08
256.87
u/l
0.41
241
895
106
227
5.14
47.42
2.6
1.5
—
—
—
0
0
270
1150
2.90
43.59
7.7
5.1
1.08
1.04
mmol/l
1.81
258
1057
204
794
3.01
38.31
2.6
2.4
0.20
0.21
g/l
0.45
190
739
298
1418
2.62
38.04
3.8
3.4
0.79
0.82
mmol/l
4.28
283
1345
197
758
3.03
37.71
8.5
6.6
11.49
9.90
mmol/l
1.96
189
723
798
6025
3.26
37.37
9.2
4.3
18.72
12.52
mm/h
16.28
772
5624
644
4389
2.51
36.67
6.6
3.9
5.47
5.35
estimate
0.01
251
918
638
4331
2.50
36.62
6.6
3.9
0.00
0.00
estimate
0.31
246
898
641
4416
2.45
34.70
6.7
3.9
0.00
0.36
estimate
0.51
233
857
51
74
7.23
33.78
1.7
2.6
549.00
1221.15
mg
1.31
51
74
392
2213
2.33
33.54
3.2
2.3
3.30
2.92
mg/l
1.90
354
1877
96
250
4.17
33.42
3.9
3.8
1.75
1.52
mg/l
1.15
88
218
585
3913
2.33
33.28
24.4
15.7
1.31
1.28
inr
0.74
519
3239
154
559
3.10
32.33
1.7
1.3
344.94
249.08
u/ml
0.37
148
514
374
2104
2.30
31.90
3.9
2.7
362.76
345.43
umol/l
2.12
342
1845
113
345
3.59
31.33
1.7
2.0
38.68
39.72
u/l
0.21
90
308
314
1652
2.36
31.21
2.0
1.5
3.27
2.49
g/l
5.11
251
990
49
75
6.84
30.89
1.4
1.2
—
—
—
0
0
87
225
4.16
30.52
1.9
2.7
218.43
197.80
%
1.08
82
218
613
4278
2.26
30.11
10.1
7.1
1.21
1.21
mmol/l
1.89
507
3685
798
6267
2.90
29.99
15.0
8.1
82.55
79.12
u/l
1.67
776
5924
283
1445
2.38
29.92
2.5
1.9
—
—
—
0
0
407
2420
2.21
29.84
7.1
3.9
0.00
0.01
estimate
1.15
230
828
100
292
3.72
29.58
3.3
3.9
42.79
57.05
mg/l
0.49
83
254
58
110
5.56
29.51
1.2
1.1
—
—
—
0
0
169
682
2.81
29.12
5.5
3.5
1.22
1.23
mmol/l
1.20
156
593
99
291
3.69
28.99
3.4
3.9
57.06
70.56
mg/l
0.27
82
252
558
3789
2.18
28.80
4.3
2.9
167.45
130.93
ug/l
1.29
526
3504
563
3845
2.17
28.52
8.9
6.5
1.21
1.21
mmol/l
1.25
526
3532
618
4383
2.22
28.36
9.0
6.7
10.92
11.64
umol/l
1.21
601
4183
70
162
4.59
28.30
5.9
4.5
2.97
2.60
mmol/l
0.38
53
107
93
267
3.76
28.17
3.3
3.7
3.16
2.64
ratio
0.13
48
158
55
105
5.50
27.78
1.2
1.1
132.64
118.22
%
1.22
55
97
423
2608
2.14
27.72
2.7
2.1
145.68
249.64
u/l
1.97
397
2480
255
1285
2.36
27.47
2.2
2.0
30.65
29.50
s
1.38
250
1248
113
378
3.26
27.02
1.6
2.0
1.50
1.52
g/l
0.08
99
337
111
368
3.29
26.93
2.6
1.8
2.07
2.67
ug/l
0.23
104
327
426
2659
2.11
26.77
4.3
3.3
1825.51
1371.55
ng/l
1.56
386
2275
444
2826
2.09
26.36
5.7
4.0
16.07
8.34
mg/mmol
1.90
318
1742
79
213
3.96
26.13
1.7
2.2
11.37
11.99
mg/l
0.25
73
199
389
2368
2.10
25.91
5.4
3.4
1.26
0.05
estimate
0.47
199
718
541
3720
2.08
25.88
3.3
2.4
78.38
77.27
nmol/l
0.39
507
3336
42
66
6.62
25.81
1.3
1.2
—
—
—
0
0
42
66
6.62
25.81
1.3
1.2
—
—
—
0
0
150
608
2.75
25.44
2.4
1.6
—
—
—
0
0
262
1378
2.25
25.22
1.4
1.3
8.48
13.27
u/ml
0.84
94
495
41
65
6.55
24.98
1.3
1.2
—
—
—
0
0
41
65
6.55
24.98
1.3
1.2
—
—
—
0
0
64
155
4.36
24.41
4.3
5.3
1078.50
350.41
iu/ml
—
8
17
448
2929
2.02
24.02
4.6
3.2
6.89
7.65
mmol/l
3.61
387
2460
42
73
5.98
23.38
1.3
1.2
—
—
—
0
0
82
250
3.50
22.64
1.5
1.5
0.20
0.08
iu/ml
0.50
24
49
647
4885
2.06
22.37
6.8
5.2
6.88
6.69
mmol/l
1.39
628
4649
215
1090
2.26
22.30
2.4
1.8
—
—
—
0
0
31
41
7.79
22.18
2.4
1.7
—
—
—
0
0
695
5403
2.13
21.98
7.5
4.8
23.63
2207.09
e6/l
—
8
92
31
42
7.60
21.74
1.2
1.1
—
—
—
0
0
205
1030
2.27
21.67
2.4
1.8
—
—
—
0
0
481
3313
1.93
21.30
6.7
3.9
0.00
0.07
estimate
1.28
213
762
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
83
270
3.28
20.67
3.9
2.8
0.31
0.37
iu/ml
0.83
50
141
307
1832
2.01
20.57
1.9
1.8
1.35
1.30
mg/l
0.12
262
1411
248
1370
2.10
20.52
4.6
3.0
3.45
2.69
e6/l
0.50
143
680
180
889
2.27
19.66
5.7
3.7
1.89
1.93
mmol/l
0.06
162
755
27
38
7.29
18.30
1.2
1.2
—
—
—
0
0
254
1470
2.00
18.21
4.6
2.9
0.85
1.13
e6/l
0.98
148
783
378
2509
1.85
17.81
2.1
1.7
19.01
20.27
nmol/l
0.82
323
2096
45
108
4.33
17.36
1.3
1.7
—
—
—
0
0
62
194
3.35
16.41
1.6
1.5
—
—
—
0
0
55
160
3.59
16.28
3.5
2.6
9.08
8.79
pmol/l
0.07
55
160
119
531
2.42
16.26
5.5
3.9
23.97
24.31
mmol/l
0.70
119
525
387
2645
1.79
16.15
3.5
2.6
52.18
63.72
u/l
3.31
354
2455
23
11
21.40
16.03
1.1
1.0
—
—
—
0
0
64
216
3.11
14.97
1.4
1.6
—
—
—
0
0
417
2959
1.74
14.94
4.2
3.5
2.34
2.36
mmol/l
1.43
392
2681
99
424
2.49
14.75
1.8
1.5
—
—
—
0
0
49
145
3.51
14.15
1.4
1.7
—
—
—
0
0
31
65
4.90
14.09
1.3
1.7
—
—
—
0
0
78
306
2.69
13.89
1.9
2.0
235.18
404.79
ug/l
0.57
69
289
312
2084
1.75
13.55
6.3
4.1
84.73
89.07
%
1.94
306
2044
41
111
3.82
13.48
1.3
1.6
—
—
—
0
0
136
694
2.12
13.40
5.9
3.5
109.05
84.13
ng/l
2.09
120
604
47
141
3.46
13.30
1.4
1.4
145.60
149.33
au/ml
0.06
15
39
105
486
2.31
13.14
5.4
3.5
2.36
2.06
mmol/l
0.38
82
356
62
222
2.92
13.09
1.4
1.6
—
—
—
0
0
239
1491
1.81
13.03
2.0
1.8
1305.84
1183.91
nmol/l
1.16
192
1125
24
23
10.68
12.79
1.3
1.2
0.32
0.28
g/l
1.15
18
18
49
155
3.28
12.76
1.3
1.2
275.24
259.81
u/ml
0.11
25
81
440
3269
1.66
12.59
5.9
3.9
54.72
66.57
ng/l
0.19
347
2379
61
222
2.87
12.51
3.5
3.4
3.72
1.85
index
0.53
32
121
271
1778
1.74
12.33
2.0
1.8
432.68
21643724.23
pmol/l
1.41
221
1497
174
1000
1.91
12.23
6.2
8.5
1.46
1.00
mmol/l
0.65
142
822
43
130
3.42
12.03
1.4
1.3
—
—
—
0
0
378
2729
1.65
11.92
3.8
3.4
36.54
32.79
u/l
0.71
345
2578
74
307
2.53
11.77
2.7
2.9
—
—
—
0
0
173
1011
1.87
11.51
3.2
2.4
125.48
128.95
ug/g
0.07
140
805
48
160
3.11
11.49
1.3
1.4
—
—
—
0
0
55
199
2.87
11.41
1.4
1.6
—
—
—
0
0
122
642
2.04
11.01
4.8
2.6
57.60
65.95
ml/min/173m2
1.71
74
272
56
209
2.79
10.98
4.0
2.0
126.66
127.94
g/l
0.13
50
164
139
768
1.95
10.92
2.7
2.3
43.26
35.54
u/l
0.42
128
641
41
130
3.25
10.66
1.1
1.1
—
1.50
—
0
8
169
1014
1.81
10.25
6.4
8.4
5.09
5.11
kpa
0.07
161
974
168
1015
1.80
9.94
6.4
8.4
11.52
12.00
kpa
0.70
161
976
31
86
3.69
9.88
1.2
1.2
—
—
—
0
0
21
43
4.97
9.82
1.9
1.6
5.93
6.99
u/l
0.09
14
35
45
161
2.89
9.55
1.3
1.5
—
—
—
0
0
50
190
2.72
9.50
1.3
1.4
—
—
—
0
0
476
3769
1.54
9.38
3.5
2.8
—
—
estimate
—
0
0
203
1316
1.69
9.33
1.7
1.6
—
—
—
0
0
159
963
1.79
9.30
3.2
2.9
8.46
7.76
umol/l
0.20
138
843
92
466
2.08
9.18
1.3
1.3
56.00
42.94
au/ml
—
5
36
127
727
1.86
8.91
3.5
2.4
0.19
0.57
e6/l
1.93
120
689
39
134
2.99
8.90
1.3
1.5
—
—
—
0
0
853
7831
2.05
8.75
39.8
16.0
23.37
24.72
mg/l
0.71
801
6446
264
1857
1.59
8.69
1.4
1.3
1.56
1.63
u/ml
0.04
88
477
42
153
2.83
8.65
1.6
1.4
—
—
—
0
0
42
153
2.83
8.65
1.6
1.4
—
—
—
0
0
20
44
4.62
8.62
2.6
1.8
459.00
474.71
e6/l
0.05
15
34
60
262
2.38
8.58
1.4
1.2
—
—
—
0
0
48
190
2.61
8.44
3.6
3.2
33.57
34.13
umol/l
0.07
43
168
97
517
1.98
8.41
2.4
2.4
16.20
18.67
au/ml
—
7
40
468
3750
1.50
8.35
2.5
2.1
92.26
94.96
pmol/l
0.59
279
1939
252
1768
1.58
8.34
3.3
3.1
2.48
2.46
mmol/l
3.12
229
1591
29
91
3.26
7.72
2.6
1.5
59.86
61.19
%
0.05
14
65
20
49
4.15
7.56
1.0
1.2
—
—
—
0
0
97
540
1.89
7.40
2.4
1.6
—
—
—
0
0
231
1629
1.56
7.36
5.4
4.1
256.73
364.48
ng/l
0.38
182
1299
41
165
2.55
7.01
1.1
1.2
80.96
38.56
u/l
0.53
32
144
17
39
4.42
6.98
1.2
1.1
0.47
0.52
ratio
—
7
24
703
6228
1.52
6.97
5.0
4.3
15.17
14.86
pmol/l
2.63
640
5681
19
48
4.02
6.91
1.5
1.5
—
—
—
0
0
13
14
9.40
6.80
1.2
1.1
—
—
—
0
0
19
50
3.86
6.56
1.5
1.5
—
—
—
0
0
43
184
2.40
6.48
1.7
1.5
—
—
—
0
0
110
675
1.71
6.08
4.4
3.2
246.90
225.04
ng/l
0.23
101
621
20
58
3.50
6.03
1.5
1.5
—
—
—
0
0
546
4672
1.41
5.99
3.3
2.9
—
—
—
0
0
51
244
2.15
5.95
1.9
1.3
—
—
—
0
0
609
5338
1.41
5.64
4.6
3.3
68.26
49.53
u/l
4.41
567
5009
43
198
2.23
5.52
3.9
3.5
0.78
0.83
nmol/l
0.27
32
168
813
7565
1.58
5.21
35.7
15.7
77.56
79.35
ml/min/173m2
1.34
789
7018
14
27
5.25
5.09
1.1
1.2
—
—
—
0
0
803
7462
1.55
5.05
8.0
6.5
40.86
39.43
mmol/mol
3.79
754
6955
22
77
2.90
4.95
2.1
3.4
15.60
13.14
index
0.27
15
49
15
41
3.70
4.94
3.3
4.2
1.47
0.87
%
0.62
15
41
16
47
3.45
4.76
1.3
1.4
—
—
—
0
0
16
48
3.37
4.62
1.3
1.4
5.46
7.69
u/l
0.72
16
40
69
404
1.76
4.53
5.6
3.2
25.21
25.18
mmol/l
0.02
69
392
8
8
10.07
4.52
1.3
1.0
—
—
—
0
0
15
37
4.10
4.42
4.1
3.4
—
—
—
0
0
18
60
3.04
4.41
1.4
2.3
763.75
616.92
ml
0.44
12
39
30
132
2.32
4.33
1.6
1.5
34.00
31.77
g/l
0.32
24
120
42
213
2.02
4.27
1.4
1.3
273.00
252.10
miu/ml
—
9
93
24
96
2.54
4.24
1.3
1.3
—
—
—
0
0
15
47
3.23
4.07
1.0
1.0
—
—
—
0
0
38
192
2.02
3.93
1.2
1.1
2.70
4.46
—
6
26
14
37
3.83
3.90
1.6
2.7
1257.50
665.03
u/ml
0.77
14
37
11
23
4.83
3.88
1.1
1.2
—
—
—
0
0
15
49
3.09
3.82
1.9
3.5
0.80
0.92
index
0.29
15
49
39
203
1.96
3.72
1.4
1.4
13.23
8.81
u/l
0.96
27
160
785
7363
1.42
3.71
6.2
5.3
1.95
1.94
mu/l
0.14
729
6776
58
344
1.73
3.68
1.7
1.5
0.36
0.28
mg/l
0.36
34
154
7
9
7.83
3.56
1.3
1.3
—
—
—
0
0
37
194
1.94
3.48
2.2
2.4
111.47
57.49
ug/min
0.49
21
116
11
27
4.11
3.40
1.3
1.2
11.39
9.34
ug/l
0.30
11
27
17
65
2.65
3.31
1.5
1.5
—
—
—
0
0
17
65
2.65
3.31
1.5
1.5
—
—
—
0
0
17
65
2.65
3.31
1.5
1.5
—
—
—
0
0
246
1995
1.32
3.29
3.2
2.4
—
—
—
0
0
9
19
4.77
3.24
1.0
1.2
—
—
—
0
0
13
39
3.37
3.23
1.3
1.6
—
1224630.00
—
0
5
844
8068
1.49
3.16
40.6
19.3
139.17
139.65
mmol/l
6.16
833
7914
25
119
2.13
3.06
1.2
1.1
—
—
—
0
0
6
8
7.54
3.06
12.0
12.3
4.82
5.70
mmol/l
—
6
8
20
87
2.33
3.02
2.3
1.5
—
—
—
0
0
844
8080
1.47
3.01
41.1
19.5
3.98
3.98
mmol/l
0.03
831
7911
42
242
1.77
2.99
1.5
1.3
—
—
—
0
0
73
487
1.54
2.96
9.2
11.6
15.14
15.77
%
1.44
73
465
866
8341
1.54
2.92
46.3
21.3
88.45
78.32
umol/l
5.91
860
8244
15
58
2.61
2.88
1.1
1.2
—
—
—
0
0
7
13
5.42
2.87
1.1
1.4
—
—
—
0
0
38
216
1.79
2.84
1.3
1.3
—
—
—
0
0
15
59
2.57
2.79
1.1
1.2
—
—
—
0
0
858
8261
1.49
2.75
23.7
12.0
26.82
25.97
u/l
0.91
841
8023
17
72
2.39
2.73
1.6
1.2
0.20
2.05
u/ml
—
6
39
71
1023
0.67
2.73
5.9
4.9
32.04
32.27
%
0.07
51
656
55
356
1.58
2.57
4.2
3.5
1205.09
4178.81
u/ml
0.52
50
307
94
682
1.42
2.54
2.6
2.5
5.57
7.30
ug/l
0.90
80
603
13
50
2.62
2.54
1.4
1.1
—
—
—
0
0
50
318
1.60
2.52
2.6
1.8
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
9
27
3.36
2.39
1.0
3.1
174.44
135.74
%
—
9
27
9
27
3.36
2.39
2.9
2.0
35.88
40.73
g/l
—
9
27
22
111
2.01
2.37
1.1
1.1
1.78
2.04
—
7
16
10
33
3.05
2.36
1.1
1.2
133.90
184.41
mmol/24h
—
10
33
20
99
2.04
2.27
1.5
1.4
9193.70
44278.45
e6/l
—
10
53
8
23
3.50
2.27
2.3
1.8
100.88
101.61
nmol/24h
—
8
23
8
23
3.50
2.27
1.0
1.3
—
—
—
0
0
22
113
1.97
2.27
1.5
1.4
1452.14
1575.65
e6/l
0.07
14
74
33
194
1.73
2.25
1.5
2.0
3104.53
4646.93
u/l
—
8
78
18
86
2.11
2.24
1.1
1.1
—
—
—
0
0
8
24
3.35
2.18
1.1
1.0
—
—
—
0
0
14
61
2.31
2.15
2.3
2.6
8.74
8.10
mmol/l
0.18
14
61
14
61
2.31
2.15
1.0
1.0
—
—
—
0
0
46
300
1.56
2.12
2.4
1.7
—
—
—
0
0
6
15
4.02
2.04
1.0
1.0
—
—
—
0
0
40
255
1.59
2.04
1.5
1.5
269.17
291.52
ug/g
0.29
24
160
10
38
2.65
2.01
1.7
1.5
—
—
—
0
0
10
38
2.65
2.01
1.7
1.5
—
—
—
0
0
10
38
2.65
2.01
1.7
1.5
—
—
—
0
0
10
38
2.65
2.01
1.7
1.5
—
—
—
0
0
10
38
2.65
2.01
1.3
1.2
—
—
—
0
0
42
273
1.56
1.98
1.6
1.6
—
—
—
0
0
37
236
1.59
1.90
1.3
1.1
—
—
—
0
0
36
549
0.64
1.87
1.5
1.7
3.58
3.46
mmol/l
0.22
21
403
15
72
2.10
1.87
1.1
1.1
111.87
108.08
pmol/l
0.14
15
72
9
34
2.66
1.87
1.3
1.1
—
—
—
0
0
16
79
2.04
1.86
1.0
1.4
—
—
—
0
0
7
23
3.06
1.80
1.1
2.3
—
421.58
—
0
5
8
29
2.77
1.79
1.4
1.1
2.91
4.69
umol/l
—
8
24
117
933
1.29
1.77
2.1
1.8
1.76
1.49
%
2.54
99
809
69
509
1.38
1.76
1.3
1.2
124.22
125.55
u/ml
0.01
33
212
28
170
1.67
1.75
1.1
1.7
4.45
796.57
e6/l
0.65
20
135
54
747
0.71
1.72
1.6
2.0
3.67
3.51
ratio
0.26
37
598
35
227
1.56
1.70
1.9
1.6
10712.23
15643.48
e6/l
0.51
26
157
20
111
1.82
1.69
1.5
1.3
0.52
16.66
nmol/l
0.50
20
106
114
913
1.28
1.67
3.9
4.5
72.34
27.15
ug/l
0.47
90
759
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
10
40
2.52
1.67
1.1
1.1
—
—
—
0
0
18
98
1.85
1.62
1.2
1.2
0.15
0.19
nmol/l
—
10
75
10
42
2.40
1.62
1.4
1.3
82.40
98.19
nmol/l
—
10
30
12
56
2.16
1.61
1.1
1.6
14.31
13.85
umol/l
0.07
12
50
27
168
1.63
1.56
1.1
1.6
6.94
32.36
e6/l
0.68
18
129
10
44
2.29
1.56
1.1
1.1
—
—
—
0
0
53
388
1.39
1.45
1.3
1.3
—
—
—
0
0
5
16
3.14
1.44
1.0
1.0
—
—
—
0
0
7
29
2.42
1.39
2.7
3.5
10.51
9.70
kpa
—
7
29
7
29
2.42
1.39
2.7
3.5
4.67
5.06
kpa
—
7
29
34
235
1.46
1.28
1.3
1.1
—
—
—
0
0
18
107
1.70
1.26
1.7
1.5
0.17
0.34
nmol/l
1.91
13
80
14
77
1.83
1.26
1.9
1.3
9311.67
185541.96
e6/l
—
6
52
786
7620
1.20
1.25
5.7
5.2
6.04
5.97
mmol/l
0.43
723
6960
222
1965
1.17
1.24
7.3
4.0
1.02
1.78
kg/l
0.50
159
1318
11
57
1.94
1.17
1.5
2.1
21.09
21.73
nmol/l
0.06
11
52
44
326
1.37
1.16
1.7
1.4
24.25
27.05
iu/l
0.22
38
270
8
39
2.06
1.15
1.1
1.2
18.50
8.77
mm/h
—
8
39
761
7373
1.18
1.13
4.5
4.3
1.40
1.29
mmol/l
3.03
697
6737
14
80
1.76
1.13
1.6
1.8
—
—
—
0
0
8
40
2.01
1.12
1.0
1.0
1302.25
1498.10
miu/ml
—
8
40
13
73
1.79
1.11
1.3
1.2
1.11
1.56
nmol/l
0.96
13
63
25
168
1.50
1.10
1.1
1.5
1.22
0.89
nmol/l
0.86
19
142
868
8521
1.27
1.07
53.8
24.6
253.82
247.98
e9/l
1.46
857
8351
868
8522
1.27
1.06
53.6
24.5
92.05
91.20
fl
5.10
862
8426
10
52
1.93
1.06
1.5
1.9
—
—
—
0
0
868
8524
1.27
1.05
53.8
24.5
4.32
4.47
e12/l
12.87
856
8328
868
8524
1.27
1.05
54.3
25.1
39.35
40.19
%
5.90
862
8422
868
8527
1.26
1.02
54.3
24.7
129.53
134.77
g/l
19.43
862
8428
9
48
1.88
1.00
1.6
1.6
—
—
—
0
0
13
76
1.72
0.99
1.1
1.1
—
—
—
0
0
59
469
1.28
0.99
2.9
3.4
4.17
4.53
pmol/l
2.17
51
422
17
108
1.58
0.97
1.1
1.0
—
—
—
0
0
9
51
1.77
0.94
1.7
1.2
—
—
—
0
0
9
51
1.77
0.94
1.7
1.2
—
—
—
0
0
14
85
1.66
0.94
1.6
1.3
—
—
—
0
0
7
37
1.90
0.94
1.1
1.2
—
—
—
0
0
806
7879
1.17
0.89
6.0
5.8
2.49
2.68
mmol/l
7.12
735
7291
29
211
1.39
0.89
1.1
1.2
—
—
—
0
0
8
46
1.75
0.82
1.6
1.2
—
—
—
0
0
16
106
1.52
0.79
4.1
3.5
—
—
—
0
0
12
74
1.63
0.78
1.8
2.1
17.17
8.24
umol/l
0.62
12
54
793
7760
1.15
0.78
5.4
5.1
4.38
4.61
mmol/l
7.22
726
7210
788
7715
1.14
0.73
5.3
5.0
1.40
1.47
mmol/l
4.20
721
7121
13
84
1.56
0.72
1.6
1.6
—
—
—
0
0
5
26
1.93
0.70
2.4
1.6
—
—
—
0
0
5
26
1.93
0.70
2.4
1.6
—
—
—
0
0
11
69
1.60
0.68
1.4
1.3
—
—
—
0
0
11
69
1.60
0.68
1.3
1.5
39.01
48.55
ug/l
0.69
11
69
5
27
1.86
0.68
2.4
1.6
—
—
—
0
0
12
78
1.55
0.65
1.7
1.7
—
—
—
0
0
8
49
1.64
0.62
1.8
1.4
87.25
84.57
umol/l
—
8
49
11
72
1.53
0.59
2.5
2.4
—
—
—
0
0
6
36
1.67
0.56
1.8
1.1
—
—
—
0
0
6
36
1.67
0.56
1.8
1.1
—
—
—
0
0
351
3339
1.08
0.55
2.0
1.9
1.36
1.35
mmol/l
0.13
264
2825
34
278
1.23
0.52
1.5
1.6
24.45
10.78
u/ml
—
8
56
10
67
1.50
0.50
1.0
1.0
—
—
—
0
0
7
45
1.56
0.49
1.1
1.5
—
—
—
0
0
7
45
1.56
0.49
1.1
1.5
—
—
—
0
0
76
677
1.13
0.45
2.7
2.4
13.18
13.24
nmol/l
0.02
66
612
8
56
1.43
0.42
1.8
1.7
86.88
96.52
ng/l
—
8
56
17
131
1.30
0.42
1.6
1.6
—
—
—
0
0
8
58
1.38
0.41
1.1
1.7
3.23
3.67
ug/l
—
8
50
5
33
1.52
0.41
1.0
1.1
—
—
—
0
0
5
37
1.35
0.37
1.0
2.2
—
—
—
0
0
19
155
1.23
0.32
1.2
1.1
0.64
2.13
u/ml
1.45
11
89
68
747
0.90
0.32
2.8
2.1
—
—
—
0
0
62
684
0.90
0.32
2.8
2.0
—
—
—
0
0
46
410
1.13
0.30
2.6
3.3
47.11
88.58
u/ml
0.65
46
397
13
104
1.25
0.26
2.1
1.3
—
—
—
0
0
34
383
0.88
0.26
2.1
2.1
—
—
—
0
0
13
106
1.23
0.23
2.2
1.3
—
—
—
0
0
13
106
1.23
0.23
2.2
1.3
—
—
—
0
0
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
12
98
1.23
0.21
1.6
1.7
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
51.88
—
0
7
90
946
0.95
0.17
13.3
6.6
—
—
—
0
0
199
2050
0.96
0.17
4.1
4.5
21.66
21.42
%
0.07
87
986
12
101
1.19
0.16
2.3
1.3
—
—
—
0
0
12
101
1.19
0.16
2.3
1.3
—
—
—
0
0
111
1066
1.05
0.15
1.6
1.4
—
—
—
0
0
12
102
1.18
0.15
2.3
1.3
—
—
—
0
0
262
2567
1.03
0.13
5.0
5.6
2.25
2.80
ug/l
0.56
235
2318
11
95
1.16
0.11
1.1
1.0
4.20
2.07
eliau/ml
—
6
33
36
383
0.94
0.11
1.0
1.0
—
—
—
0
0
66
634
1.04
0.10
1.6
1.5
—
—
—
0
0
19
205
0.93
0.08
1.5
1.4
—
—
—
0
0
24
226
1.06
0.06
1.3
1.5
—
—
—
0
0
150
1523
0.98
0.05
2.8
3.2
0.63
0.78
ug/l
1.44
102
968
26
253
1.03
0.01
2.1
1.9
33.69
38.38
nmol/l
0.72
26
239
32
316
1.01
0.00
2.1
2.0
—
—
—
0
0
7
74
0.95
-0.00
1.0
1.6
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
0.01
—
0
5
0
7
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.7
—
0.67
—
0
6
0
6
0.00
-0.00
0.0
1.5
—
6.22
—
0
6
Mortality – FinRegistry
↥Association
Association between endpoint L12_VASCULITISNAS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| L12_VASCULITISNAS | 2.781 [2.39, 3.24] | < 0.001 |
| Birth year | 0.995 [0.99, 1.0] | 0.216 |
During the follow-up period (1.1.1998 — 31.12.2019), 1063 out of 2856 females with L12_VASCULITISNAS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| L12_VASCULITISNAS | 2.679 [2.22, 3.24] | < 0.001 |
| Birth year | 0.99 [0.98, 1.0] | 0.032 |
During the follow-up period (1.1.1998 — 31.12.2019), 699 out of 1962 males with L12_VASCULITISNAS died.
Mortality risk
Mortality risk for people of age
years, who have L12_VASCULITISNAS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.272% | 0.627% |
| 5 | 1.768% | 3.441% |
| 10 | 4.143% | 8.225% |
| 15 | 8.192% | 15.612% |
| 20 | 13.626% | 25.911% |
Relationships between endpoints
↥Index endpoint: L12_VASCULITISNAS – Other and unspecified vasculitis limited to skin
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data